Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingxin Zhidong formula (JXZDF) is a traditional Chinese medicine herbal formulation widely used in China for the treatment of tic disorders, including Tourette syndrome. It is composed of multiple herbal ingredients and has been evaluated in randomized controlled trials for its efficacy and safety compared to standard pharmaceutical treatments such as aripiprazole. Clinical studies have shown that JXZDF can produce significant improvements in tic severity with a lower incidence of adverse events than aripiprazole, suggesting it may be a safer alternative or adjunctive therapy for pediatric patients with tic disorders[1][2][4]. The precise mechanism of action is not fully elucidated but likely involves modulation of neurotransmitter systems and neuroinflammation based on network pharmacology analyses[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jingxin Zhidong formula.